Sponsors
The bill centralizes toxic-exposure programs and creates a national registry to streamline administration and improve tracking, but does so at the risk of losing dedicated ATSDR expertise, disrupting services and studies, shifting costs to taxpayers and states, and narrowing legal and statutory avenues for exposure-related accountability.
State public-health agencies and patients with chronic conditions: creation of a national registry for serious diseases and toxic exposures will improve tracking of exposures and health outcomes across states.
Hospitals, state and local governments, and HHS staff: consolidating program authority and removing duplicate statutory references clarifies administration and oversight, reducing interagency confusion and potentially improving coordination.
State and local governments and program partners: authorizing HHS to fold registry authority into an existing component can reduce administrative overhead by eliminating a separate agency structure.
State and local public-health agencies, hospitals, and exposed communities: abolishing or removing ATSDR references risks losing specialized federal toxic-exposure expertise and statutory roles, weakening disease surveillance, exposure assessment, and timely response to contamination events.
Communities affected by toxic exposures, including rural and disabled populations: ending ATSDR programs may reduce research, outreach, and remediation support, slowing identification and remediation of exposure-related illnesses.
Patients in ongoing studies, hospitals, and community health programs: transferring or winding down programs and grants could disrupt ongoing studies, community health investigations, and services for exposed individuals.
Based on analysis of 3 sections of legislative text.
A standalone federal toxic‑substances health agency is abolished after one year and its national registry authority and functions are moved into HHS/CDC through statutory conforming changes.
Introduced January 3, 2025 by Andrew S. Biggs · Last progress January 3, 2025
A federal public health agency (the Agency for Toxic Substances and Disease Registry) would be abolished one year after the law takes effect, with its core disease- and exposure‑registry authority moved into another part of the Department of Health and Human Services. The Secretary of HHS must wind down the Agency during the year before abolition, transfer statutory authority for national disease and exposure registries to an appropriate HHS office, and may transfer staff, funds, records, and other assets within HHS to continue those functions. The bill also makes many changes to federal statutes to remove or alter references to the abolished agency, revises a CERCLA provision to place responsibility for national registries with the HHS Secretary (working with states), deletes several statutory subsections that referenced the agency, and narrows or removes the agency from lists of consultative or program partners across several laws. Two targeted edits require certain programs to be placed within the Centers for Disease Control and Prevention rather than elsewhere.